Slowing Parkinson’s disease progression: Recent dopamine agonist trials
- 27 January 2004
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 62 (2) , 343-345
- https://doi.org/10.1212/wnl.62.2.343
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Rationale for the use of dopamine agonists as neuroprotective agents in Parkinson's diseaseAnnals of Neurology, 2003
- Agonists vs levodopa in PDNeurology, 2003
- Slowing Parkinson’s disease progressionNeurology, 2003
- Initial agonist treatment of Parkinson diseaseNeurology, 2003
- Dopamine Transporter Brain Imaging to Assess the Effects of Pramipexole vs Levodopa on Parkinson Disease ProgressionJAMA, 2002
- Neuroprotective effect of riluzole in a primate model of Parkinson's disease: Behavioral and histological evidenceMovement Disorders, 2002
- Pramipexole vs Levodopa as Initial Treatment for Parkinson DiseaseJAMA, 2000
- A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or LevodopaNew England Journal of Medicine, 2000
- Factor structure of the unified Parkinson's disease rating scale: Motor examination sectionMovement Disorders, 1998
- Early Treatment of Parkinson??s Disease with Cabergoline Delays the Onset of Motor ComplicationsDrugs, 1998